| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 01/02/2003 | EP1268774A2 Identification of essential genes in prokaryotes |
| 01/02/2003 | EP1268773A1 Immune system-related polynucleotides, polypeptides, and antibodies |
| 01/02/2003 | EP1268772A2 Peptide and nucleic acid coding therefor for the detection, diagnosis and therapy of diseases of the nervous system |
| 01/02/2003 | EP1268771A1 Human gata-5 transcription factor |
| 01/02/2003 | EP1268555A2 Ligands directed to the non-secretory component, non-stalk region of pigr and methods of use thereof |
| 01/02/2003 | EP1268554A2 Diagnostic and medicament for analysing the cell surface proteome of tumour and inflammatory cells and for treating tumorous and inflammatory diseases, preferably using a specific chemokine receptor analysis and the chemokine receptor-ligand interaction |
| 01/02/2003 | EP1268550A2 Human fap-alpha-specific antibodies |
| 01/02/2003 | EP1268545A1 Potassium channel protein kcnq5, a target for diseases of central nervous system and cardiovascular system |
| 01/02/2003 | EP1268543A2 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
| 01/02/2003 | EP1268541A1 7 human ovarian and ovarian cancer associated proteins |
| 01/02/2003 | EP1268540A2 Proteins amf-1 to amf-10 and nucleic acids encoding same |
| 01/02/2003 | EP1268530A1 Hepatitis b core antigen fusion proteins |
| 01/02/2003 | EP1268528A2 Human genes and expression products |
| 01/02/2003 | EP1268527A2 Nucleic acids, proteins, and antibodies |
| 01/02/2003 | EP1268509A1 Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof |
| 01/02/2003 | EP1267940A1 Compounds for targeting |
| 01/02/2003 | EP1267934A2 A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer |
| 01/02/2003 | EP1267930A1 Cross-reactive displacing antibodies from collagen-binding proteins and method of identification and use |
| 01/02/2003 | EP1267909A1 Methods of blocking tissue destruction by autoreactive t cells |
| 01/02/2003 | EP1100949A4 Fusion products containing insoluble proteinaceous tag |
| 01/02/2003 | EP1078040A4 Nt2lp, novel g-protein coupled receptors having homology to neurotensin-2 receptors |
| 01/02/2003 | EP0725081B1 MONOCLONAL ANTIBODY AGAINST HUMAN Mx PROTEIN MxA |
| 01/02/2003 | EP0605428B9 Hormone-secreting pancreatic cells maintained in long-term culture |
| 01/01/2003 | CN1388136A Double-specificity antibody resisting human ovary cancer and human CD3 |
| 01/01/2003 | CN1388132A Cell death inducing protein and its coding sequence and use |
| 12/31/2002 | US6500945 Nucleotides having chiral phosphorus linkages |
| 12/31/2002 | US6500941 Secreted by human breast cancer mda-mb-175 cells, leads to the formation of a constitutive active receptor complex and stimulates these cells in an autocrine manner |
| 12/31/2002 | US6500932 Antihuman thymidylate synthase monoclonal antibodies and hybridomas producing the same |
| 12/31/2002 | US6500931 Portion of a complementarity determining region (cdr) derived from a non-human antibody with remaining portions human in origin; use in immunotherapy or as immunotoxins |
| 12/31/2002 | US6500923 Isolated polypeptide that binds to an autoantibody from a dermatomyositis patient to provide means by which dermatomyositis can be detected by way of differential diagnosis |
| 12/31/2002 | US6500922 Native polypeptide factors that are capable of association with the intracellular domain of tnf-r2 and participate in the intracellular post-receptor signaling of tnf biological activities |
| 12/31/2002 | US6500919 Melanoma associated antigenic polypeptide, epitopes thereof and vaccines against melanoma |
| 12/31/2002 | US6500674 Method for the diagnosis of brain/neurological disease using monoclonal antibodies specific for PHF-tau, hybridomas secreting them, and antigen recognition by these antibodies and their applications |
| 12/31/2002 | US6500672 A competitive assay for binding activity to recombinant hepatocyte nuclear factor-4 receptors, a chimeric receptor comprising the ligand binding domain of a hnf-4 receptor and dna binding domain of another receptor |
| 12/31/2002 | US6500664 Growth differentiation factor-8 family nucleic acid sequences |
| 12/31/2002 | US6500662 Infectious cdna clones of positive polarity rna viruses and the construction of vaccines, in particular, swine vaccines, using such cdna clones |
| 12/31/2002 | US6500659 A thermostable enzyme that catalyzes the removal of arginine, phenylalanine, or methionine from the n-terminal end of peptides |
| 12/31/2002 | US6500653 Nucleic acids and polypeptides which resemble RHO and which interact with cell signaling pathways and proteins |
| 12/31/2002 | US6500648 Methods for recombinant peptide production |
| 12/31/2002 | US6500647 Recombinant expression vector which is prepared by inserting a human parathyroid hormone gene containing a urokinase-specific cleavage site into an l-arabinose inducible vector containing a phosphoribulokinase gene fragment of |
| 12/31/2002 | US6500646 Drugs in which peptides having affinity specific for phospholipids, preferably those which are contained in the constituents of lipid bilayers forming the surface layers of cells and of which the proportion in the outer part of each |
| 12/31/2002 | US6500642 Mammalian cdna which encodes a mammalian mapop-3. it also provides for the use of the cdna, fragments, complements, and variants thereof and of the encoded protein, portions thereof and antibodies thereto for diagnosis and treatment of breast |
| 12/31/2002 | US6500636 Chimeric pre-activated transcription factors |
| 12/31/2002 | US6500634 Neurotransmission by excitatory amino acids (eaas) such as glutamate is mediated via membrane-bound surface receptors. dna coding for eaa receptors of one family of human nmda-binding type receptors has now been isolated and receptor |
| 12/31/2002 | US6500624 Kainate-binding, human CNS receptors of the EAA3 family |
| 12/31/2002 | CA2201944C Analogs of keratinocyte growth factor having enhanced temperature stability |
| 12/31/2002 | CA2157867C High molecular weight surface proteins of non-typeable haemophilus |
| 12/31/2002 | CA2096532C New human recombinant gamma-interferon |
| 12/31/2002 | CA2016313C Process for preparing an improved western blot immunoassay |
| 12/31/2002 | CA1341414C Expression vectors of hirudine, transformed cells and process for the preparation of hirudine |
| 12/27/2002 | WO2002103027A1 Glycoprotein and process for producing the same |
| 12/27/2002 | WO2002103026A2 Method for the recombinant production of peptidic antiviral fusion inhibitors, and acetylation of gb41 fragments |
| 12/27/2002 | WO2002103024A2 Stabilized proteins with engineered disulfide bonds |
| 12/27/2002 | WO2002103016A2 Human tachykinin-related splice variants and compositions thereof |
| 12/27/2002 | WO2002103008A2 Templated molecules and methods for using such molecules |
| 12/27/2002 | WO2002102990A2 Fibroblast growth factor and nucleic acid encoding same |
| 12/27/2002 | WO2002102853A2 Cd4-specific antibody trx1 and uses therefor |
| 12/27/2002 | WO2002102839A2 Novel g-protein coupled receptors and dna sequences thereof |
| 12/27/2002 | WO2002102836A2 Moraxella (branhamella) catarrhalis antigens |
| 12/27/2002 | WO2002102829A2 Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus |
| 12/27/2002 | WO2002102320A2 Fce fusion proteins for treatment of allergy and asthma |
| 12/27/2002 | WO2002102310A2 Proteins associated with cell growth, differentiation, and death |
| 12/27/2002 | WO2002102302A2 Method of preparing and formulations including hydrolyzed jojoba protein |
| 12/27/2002 | WO2002090533A9 Enhanced production of recombinant proteins by transient transfection of suspension-growing mammalian cells |
| 12/27/2002 | WO2002062973A3 Lipase variants |
| 12/27/2002 | WO2002040515A3 Exoenzyme toxin of aeromonas salmonicida, and uses thereof |
| 12/27/2002 | WO2002040514A3 Type iii secretion pathway in aeromonas salmonicida, and uses therefor |
| 12/27/2002 | WO2002024869A3 Elicitor of fungal origin and method for its preparation |
| 12/27/2002 | WO2002012467A3 Drug metabolizing enzymes |
| 12/27/2002 | WO2002012279A3 Schizophrenia related gene and protein |
| 12/27/2002 | WO2002010414A3 Expression of biologically active polypeptides in duckweed |
| 12/27/2002 | WO2002008257A3 Siglec (sialic acid-binding ig-related lectin) polypeptides and uses thereof |
| 12/27/2002 | WO2001094587A3 Extracellular messengers |
| 12/27/2002 | WO2001085937A3 Regulator of g protein signalling (rgs8) |
| 12/27/2002 | WO2001074903A9 Cd20/ige-receptor like molecules and uses thereof |
| 12/27/2002 | WO2001057217A9 Expression and secretion vector for human interferon alpha and process for producing human interferon alpha by employing same |
| 12/27/2002 | CA2680376A1 Flax (linum usitatissimum l.) seed-specific promoters |
| 12/27/2002 | CA2455387A1 Fce fusion proteins for treatment of allergy and asthma |
| 12/27/2002 | CA2455254A1 Moraxella (branhamella) catarrhalis antigens |
| 12/27/2002 | CA2451524A1 Templated molecules and methods for using such molecules |
| 12/27/2002 | CA2450732A1 Stabilized proteins with engineered disulfide bonds |
| 12/27/2002 | CA2450700A1 Trx1 antibody and uses therefor |
| 12/27/2002 | CA2450067A1 Proteins associated with cell growth, differentiation, and death |
| 12/27/2002 | CA2446285A1 Fibroblast growth factor and nucleic acid encoding same |
| 12/27/2002 | CA2445261A1 Human tachykinin-related splice variants and compositions thereof |
| 12/26/2002 | US20020199213 Transgenic transchromosomal rodents for making human antibodies |
| 12/26/2002 | US20020198367 DNA encoding mammalian neuropeptide FF (NPFF) receptors and uses thereof |
| 12/26/2002 | US20020198366 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/26/2002 | US20020198363 Generation of antithrombic protein; obtain nucleotide sequences coding antithrombic protein, transform microorganism, express nucleotide sequences, recover protein |
| 12/26/2002 | US20020198166 Method for treatment of cancer and infectious diseases and compositions useful in same |
| 12/26/2002 | US20020198164 A toxin gene is expressed under the transcriptional control of a human prostate-specific transcriptional regulatory sequence |
| 12/26/2002 | US20020198149 Polypeptides fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides; native membrane-bound proteins; PRO polypeptides |
| 12/26/2002 | US20020198148 Polypeptides fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides; native membrane-bound proteins; PRO polypeptides |
| 12/26/2002 | US20020198147 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/26/2002 | US20020198143 B7-like polynucleotides, polypeptides, and antibodies |
| 12/26/2002 | US20020197712 Polypeptide for use as tools in analyzing enzymatic gene expression |
| 12/26/2002 | US20020197700 Receptor of the EDb-fibronectin domains |
| 12/26/2002 | US20020197693 Novel molecules of the card-related protein family and uses thereof |
| 12/26/2002 | US20020197682 Generation of preferentiaL polypetide in culture; obtain mutant aspergillus, culture, recover preferential poison polypeptide |
| 12/26/2002 | US20020197681 Identification and uses of a hyaluronan receptor for endocytosis |